Notice of Intent to Publish a Funding Opportunity Announcement for NIDA Research Education Program for Clinical Researchers and Clinicians (R25)

Notice Number: NOT-DA-16-003

Key Dates
Release Date: November 19, 2015
Estimated Publication Date of Announcement: January 2016
First Estimated Application Due Date: May 2016
Earliest Estimated Award Date: February 2017
Earliest Estimated Start Date: April 2017

Related Announcements
PAR-13-084
PAR-16-224

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The National Institute on Drug Abuse (NIDA) intends to reissue PA-13-084 NIDA Research Education Program for Clinical Researchers and Clinicians (R25).

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Publication of the reissued funding opportunity announcement is expected by the end of January 2016 with an anticipated first receipt date in Spring 2016.

This FOA will utilize the R25 activity code.

Research Initiative Details

The overall objective of this Program is to ensure that highly trained clinical scientists will be available in adequate numbers and in appropriate scientific areas to reduce the burden of substance abuse, addiction, and their related health consequences. To accomplish this goal, the NIDA Research Education Program will support research education in the mission areas of the NIDA, for those in clinically focused careers. Participants (those receiving the research education) should be training for careers as clinical researchers, clinicians/service providers, or optimally a combination of the two. Participants (those receiving the research education experiences) may be at the following levels of professional career development: undergraduate, medical/graduate student, postdoctoral fellow, medical resident, and/or independent scientist.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Flair Lindsey
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0779
Email: [email protected]